Neus Lozano

This study demonstrates that graphene oxide can be used as a membrane-associated platform to modulate integrin signaling in cancer cells, reducing motility through RGD peptide association.

This study investigates how graphene oxide interacts differently with cancer and non-cancer cells, showing that GO uptake and effects depend on material properties and cellular responses.

This study identifies a post-operative window of blood-brain barrier disruption at the glioblastoma resection margin and demonstrates enhanced chemotherapy delivery using liposomal nanomedicines during this period.

This paper demonstrates that graphene oxide nanosheets loaded with a TLR7/8 agonist can reprogram tumor-associated macrophages in GBM to a pro-inflammatory state, reducing tumor burden.